Sponsor Pipeline

Cartesian Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
3
Recruiting
1
Phase 3
2
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT04146051
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)		 date change Primary completion pushed: 2025-07-31 -> 2026-01-05
2026-08-15 NCT04146051
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)		 date change Completion pushed: 2026-03-31 -> 2026-09-30
Active Trials by Phase
Phase 3
1
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06799247 Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach… Myasthaenia Gravis Recruiting
Phase 2
NCT07391605 Descartes-08 in Autoantibody Myositis Antisynthetase Syndrome Recruiting
NCT06038474 Descartes-08 for Patients With Systemic Lupus Erythematosus Systemic Lupus Erythematosus (SLE) Active, Not Recruiting
NCT04146051 Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) Myasthenia Gravis, Generalized Active, Not Recruiting
Phase 1/2
NCT07089121 Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders Childhood-onset Systemic Lupus Erythematous Recruiting
Disease Areas
Myasthenia Gravis (2) Lupus (SLE) (2)
Get alerts when Cartesian Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free